About Our Research
In 2019, 1.27 million deaths were attributable to bacterial AMR with the highest rates being in sub-Saharan Africa. Determining the real burden of AMR and understanding the leading resistance mechanisms, transmission routes, and the evolution of resistant pathogens are crucial to making informed, tailored location-specific policy decisions, particularly targeting infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics.
Considering the serious data gaps in many African countries, there is an urgent need to expand microbiology laboratory capacity by deploying advanced genomic centres for scalable and state-of-the-art studies to sustainably contain this important threat.
We conduct integrated, multidisciplinary and intersectoral research on crucial global health challenges and sustainable development themes. We are devoted to conducting rigorous scientific research that informs strategies and policies to improve health and well-being for all. We focus our efforts on one core AMR theme and four key pillars:
(i) Reproductive, maternal, newborn and child health
(ii) Food safety and environmental health
(iii) Communicable and non-communicable diseases (e.g. diabetes mellitus, cancers, cardiovascular, kidney and liver diseases)
(iv) Drug discovery, diagnostic development, and vaccine design.
We, therefore, contribute with our numerous activities, to sustainable development through the effective, proactive and timely management of AMR using the One Health approach to improve the health of populations in Cameroon and Africa.